Clinical and translational data commons (ctdc) and immune oncology data harmonization/mapping (iodh/m)
Ended Awarded
- Contract number
- 75N91024F00035
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,499,979
Award facts
- Contract value 100% obligated
- $7,499,979.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order under a single-award Indefinite Delivery Contract between the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, and the prime contractor Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract covers Clinical and Translational Data Commons (CTDC) and Immune Oncology Data Harmonization/Mapping (IODH/M) services, with a ceiling value of $7,499,979.00. The work will be performed at Leidos Biomedical Research facilities in Fort Detrick, Maryland. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. has previously supported various biomedical research programs at the National Institutes of Health, including efforts related to cancer, HIV/AIDS, influenza, COVID-19, and gene therapy.
Quick answers
Who was awarded contract 75N91024F00035?
75N91024F00035 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2024.
How much is contract 75N91024F00035 worth?
The government has obligated $7,499,979 on 75N91024F00035.
Which agency awarded contract 75N91024F00035?
National Cancer Institute (National Institutes of Health) awarded 75N91024F00035, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91024F00035 an order under another contract?
Yes. 75N91024F00035 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00035 competed?
The extent of competition for 75N91024F00035 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award